Tata India Pharma & Healthcare Fund-Direct (IDCW)
| Fund Class | : | Equity - Pharma |
| Fund House | : | Tata Mutual Fund |
| Aum(Rs Cr) | : | 73.67 |
| NAV 25 May 2022 | 17.41 | -0.16 (-0.91%) |
NAV High-Low (in Rs)
| ONE Mth | 538.47 |
|
538.47 |
| 52-WEEk | 528.26 |
|
609.91 |
Trailing Returns
Competitors of Tata India Pharma & Healthcare Fund-Direct (IDCW) fund
| Schemes | FUND SIZE(  ) |
1-Wk (%) |
1-Mth (%) |
3-Mth (%) |
6-Mth (%) |
1-Yr (%) |
| SBI Equity Minimum Variance - Regular (IDCW) | 128.64 | -0.54 | -2.88 | -0.42 | -4.48 | 5.51 |
Fund Features
| Types of Scheme | Dividend |
| Options | Equity |
| Assets Size (Rs in Cr) | 73.67 (31 Jan 16) |
| Inception Date | 04 Dec 15 |
| Fund Manager | Meeta Shetty |
Investment Details
| Minimum Investment | 5000.00 |
| Purchase Redemption | DAILY |
| Last Dividend paid | (Rs) |
| Entry Load | 0.00% |
| EXIT Load | 0.00. |
Fund Activity
|
|
|
Equity
Net CA & Others
Reverse Repo|
|
|
Pharmaceuticals - Indian - Bulk Drugs
Pharmaceuticals - Indian - Bulk Drugs & Formln
Pharmaceuticals - Indian - Formulations
Pharmaceuticals - Multinational|
|
|
LupinFund DETAILS
Asset Management Co.
Registered Address
Tata Asset Management Ltd,
1903 B-Wing Parinee Crescenzo
G-Block Bandra Kurla Complex
Bandra East Mumbai - 400051
Phone: 6657 8282. | Fax: 2261 3782.
Email: service@tataamc.com
Website: www.tatamutualfund.com
